New Zealand - English - Medsafe (Medicines Safety Authority)

abbott laboratories (nz) ltd - sibutramine hydrochloride monohydrate 15mg - capsule - 15 mg - active: sibutramine hydrochloride monohydrate 15mg excipient: colloidal silicon dioxide gelatin   indigo carmine iron oxide black lactose monohydrate magnesium stearate microcrystalline cellulose propylene glycol shellac sodium laurilsulfate   titanium dioxide  

New Zealand - English - Medsafe (Medicines Safety Authority)

abbott laboratories (nz) ltd - sibutramine hydrochloride monohydrate 10mg equivalent to 8.37 mg sibutramine base. - capsule - 10 mg - active: sibutramine hydrochloride monohydrate 10mg equivalent to 8.37 mg sibutramine base. excipient: colloidal silicon dioxide gelatin indigo carmine iron oxide black lactose monohydrate magnesium stearate microcrystalline cellulose opacode grey s-1-27641 propylene glycol quinoline yellow shellac sodium laurilsulfate titanium dioxide

New Zealand - English - Medsafe (Medicines Safety Authority)

abbott laboratories (nz) ltd - sibutramine hydrochloride monohydrate 15mg equivalent to to 12.55 mg sibutramine base - capsule - 15 mg - active: sibutramine hydrochloride monohydrate 15mg equivalent to to 12.55 mg sibutramine base excipient: colloidal silicon dioxide gelatin indigo carmine iron oxide black lactose monohydrate magnesium stearate microcrystalline cellulose opacode grey s-1-27641 propylene glycol shellac sodium laurilsulfate titanium dioxide

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - promazine hydrochloride - oral tablet - 25mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - promazine hydrochloride - oral tablet - 50mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - moclobemide - oral tablet - 150mg

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - venlafaxine hydrochloride 169.72mg equivalent to venlafaxine 150 mg;  ;  ;   - modified release tablet - 150 mg - active: venlafaxine hydrochloride 169.72mg equivalent to venlafaxine 150 mg       excipient: cellulose acetate colloidal silicon dioxide cellulose acetate 398-10 nf macrogol 400   magnesium stearate mannitol microcrystalline cellulose opadry white y-30-18037 povidone - · arrow – venlafaxine xr is indicated for the treatment of major depression. arrow – venlafaxine xr is also indicated for the prevention of relapse and recurrence of major depression where appropriate.

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - venlafaxine hydrochloride 254.58mg equivalent to venlafaxine 225 mg;  ;  ;   - modified release tablet - 225 mg - active: venlafaxine hydrochloride 254.58mg equivalent to venlafaxine 225 mg       excipient: cellulose acetate colloidal silicon dioxide cellulose acetate 398-10 nf macrogol 400   magnesium stearate mannitol microcrystalline cellulose opadry white y-30-18037 povidone - · arrow – venlafaxine xr is indicated for the treatment of major depression. arrow – venlafaxine xr is also indicated for the prevention of relapse and recurrence of major depression where appropriate.

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - venlafaxine hydrochloride 42.43mg equivalent to venlafaxine 37.5 mg;  ;  ;   - modified release tablet - 37.5 mg - active: venlafaxine hydrochloride 42.43mg equivalent to venlafaxine 37.5 mg       excipient: cellulose acetate colloidal silicon dioxide cellulose acetate 398-10 nf macrogol 400   magnesium stearate mannitol microcrystalline cellulose opadry white y-30-18037 povidone - · arrow – venlafaxine xr is indicated for the treatment of major depression. arrow – venlafaxine xr is also indicated for the prevention of relapse and recurrence of major depression where appropriate.

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - venlafaxine hydrochloride 84.86mg equivalent to venlafaxine 75 mg;  ;  ;   - modified release tablet - 75 mg - active: venlafaxine hydrochloride 84.86mg equivalent to venlafaxine 75 mg       excipient: cellulose acetate colloidal silicon dioxide cellulose acetate 398-10 nf macrogol 400   magnesium stearate mannitol microcrystalline cellulose opadry white y-30-18037 povidone - · arrow – venlafaxine xr is indicated for the treatment of major depression. arrow – venlafaxine xr is also indicated for the prevention of relapse and recurrence of major depression where appropriate.